Beta-blockers (All routes except ocular) (versus unexposed) updated on 12-17-2024

Very preterm (28 to 32 weeks)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17127
R71771
Delteil - Beta-blockers, 2024 Very preterm birth (28-32 GW) at least 1st trimester retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: Yes Indications Antihypertensive: Only chronic indication (hypertension or cardiac) 1.94 [1.02;3.68] 10/421   617/142,505 627 421
ref
S17151
R71928
Al Khalaf - Beta-blockers (Controls unexposed, disease free), 2022 Very preterm birth (less than 32 weeks) during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed, disease free excluded Adjustment: No Indications Antihypertensive: Only chronic hypertension indication 4.15 [3.29;5.24] C
excluded (control group)
74/1,827   17,507/1,739,944 17,581 1,827
ref
S17148
R71905
Al Khalaf - Beta-blockers (Controls unexposed, sick), 2022 Very preterm birth (less than 32 weeks) during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed, sick Adjustment: No Indications Antihypertensive: Only chronic hypertension indication 1.58 [1.21;2.07] C 74/1,827   203/7,809 277 1,827
ref
S13392
R54161
Ray - Beta-blockers, 2001 Preterm birth before 32 weeks gestation during pregnancy (anytime or not specified) prospective cohort unexposed, sick Adjustment: Yes Indications Antihypertensive: Only chronic hypertension indication 4.00 [1.30;12.40] 15/144   5/247 20 144
ref
Total 3 studies 1.81 [1.27;2.59] 924 2,392
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Delteil - Beta-blockers, 2024Delteil - Beta-blockers, 2024 1.94[1.02; 3.68]62742124%ROB confusion: seriousROB selection: lowROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Al Khalaf - Beta-blockers (Controls unexposed, sick), 2022Al Khalaf - Beta-blockers, 2022 1 1.58[1.21; 2.07]2771,82767%ROB confusion: criticalROB selection: unclearROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Ray - Beta-blockers, 2001Ray - Beta-blockers, 2001 4.00[1.30; 12.40]201449%ROB confusion: moderateROB selection: lowROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Total (3 studies) I2 = 24% 1.81[1.27; 2.59]9242,3920.510.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.81[1.27; 2.59]9242,39224%NADelteil - Beta-blockers, 2024 Al Khalaf - Beta-blockers (Controls unexposed, sick), 2022 Ray - Beta-blockers, 2001 3 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.94[1.02; 3.68]627421 -NADelteil - Beta-blockers, 2024 1 unexposed, sickunexposed, sick 2.13[0.91; 4.96]2971,97159%NAAl Khalaf - Beta-blockers (Controls unexposed, sick), 2022 Ray - Beta-blockers, 2001 2 Tags Adjustment   - No  - No 1.58[1.21; 2.07]2771,827 -NAAl Khalaf - Beta-blockers (Controls unexposed, sick), 2022 1   - Yes  - Yes 2.39[1.26; 4.53]64756516%NADelteil - Beta-blockers, 2024 Ray - Beta-blockers, 2001 2 Indications Antihypertensive   - Only chronic hypertension indication  - Only chronic hypertension indication 2.13[0.91; 4.96]2971,97159%NAAl Khalaf - Beta-blockers (Controls unexposed, sick), 2022 Ray - Beta-blockers, 2001 2   - Only chronic indication (hypertensi ...  - Only chronic indication (hypertension or cardiac) 1.94[1.02; 3.68]627421 -NADelteil - Beta-blockers, 2024 1 All studiesAll studies 1.81[1.27; 2.59]9242,39224%NADelteil - Beta-blockers, 2024 Al Khalaf - Beta-blockers (Controls unexposed, sick), 2022 Ray - Beta-blockers, 2001 30.510.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 17151

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 3.02[1.44; 6.30]18,2082,24879%NADelteil - Beta-blockers, 2024 Al Khalaf - Beta-blockers (Controls unexposed, disease free), 2022 2 unexposed, sick controlsunexposed, sick controls 2.13[0.91; 4.96]2971,97159%NAAl Khalaf - Beta-blockers (Controls unexposed, sick), 2022 Ray - Beta-blockers, 2001 20.510.01.0